In ovarian cancer cells, platinum treatment can phosphorylate CDK6, which has been shown to stabilise the FOXO3 transcription factor, resulting in the upregulation of ATR, a key DNA repair factor involved in platinum resistance [12]. This evidence concerns the gene CDK6 and ovarian carcinoma.